Empagliflozin improves metabolic and hepatic outcomes in a non-diabetic obese biopsy-proven mouse model of advanced NASH
International Journal of Molecular Sciences 22:6332, 2021
Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice
Scientific Reports 11:8060, 2021
Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis
Liver International 41(8):1853-1866, 2021
Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in db/db mice
Biomedicine & Pharmacotherapy 133:110966
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach
Molecular Metabolism 21:36-50, 2019
Adrenomedullin and glucagon-like peptide-1 have additive effects on food intake in mice
Biomedicine & Pharmacotherapy 109:167-173, 2019
Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice
Physiology and Behavior 192:72-81, 2018